Jul 21, 2020

Huntsman Cancer Institute Receives Renewal of Prestigious Designation from the National Cancer Institute

The National Cancer Institute has renewed the designation of Huntsman Cancer Institute (HCI) at the University of Utah as a Comprehensive Cancer Center, the highest federal rank possible for a cancer research organization. This grant awards HCI more than $29 million over seven years, an increase of 84% in annual funding from the previous award cycle.

Mar 01, 2020

Mensaje de John Ward

Hace más de dos décadas, tuve el privilegio de ser miembro del equipo al que se le dio una oportunidad extraordinaria: trabajar junto a Jon M. y Karen Huntsman y nuestros colegas de la Universidad de Utah para transformar la forma en que brindamos atención del cáncer en Utah. Nos propusimos hacer algo que una vez se creyó imposible. Nos propusimos desarrollar un hospital de cáncer de clase mundial y un centro de investigación, Huntsman Cancer Institute (HCI por sus siglas en inglés).

Mar 01, 2020

Saving More Than Time: Shortened Radiation Therapy

Traditionally, breast cancer patients who receive radiation get small doses almost daily over a six- to seven-week period. Radiation oncologists are now seeking to shorten that time through clinical trials.

Mar 01, 2020

Message from John Ward

More than two decades ago, I had the privilege of being a member of the team given an extraordinary opportunity: to work alongside Jon M. and Karen Huntsman and our colleagues at the University of Utah to transform the way we deliver cancer care in Utah. We set out to do something once thought impossible. We set out to develop a world-class cancer hospital and research center—Huntsman Cancer Institute (HCI).

Mar 01, 2020

Ahorrando mucho más que el tiempo: la radioterapia acortada

Traditionally, breast cancer patients who receive radiation get small doses almost daily over a six- to seven-week period. Radiation oncologists are now seeking to shorten that time through clinical trials.

Jun 19, 2019

Huntsman Cancer Institute Research Discovery Leads to New Clinical Trial for Myelofibrosis Patients

Researchers at Huntsman Cancer Institute at the University of Utah discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.

Jun 06, 2019

Caring for Patients with a Family History of Pancreatic Cancer

Pancreatic cancer is relatively rare, but chances are likely you care for several patients with a family member who has been diagnosed with pancreatic cancer. New data insights outline pancreas cancer screening strategies for certain patients with a family history of the disease.

May 31, 2019

International Clinical Trial of New Drug for Men with Advanced Prostate Cancer Yields Strong Results

Today the New England Journal of Medicine published the first results of a phase III international clinical study called TITAN, which evaluated the effectiveness and safety of a new drug, apalutamide, to treat advanced prostate cancers.